It’s about time we discussed every dog owner’s least favorite ailment: tummy troubles. Vomiting, diarrhea, and supposedly ...
“Specifically, our objective is to partner with an animal health company to achieve three parallel goals for Canalevia: Expand the U.S. indication from CID in dogs to treatment of general diarrhea in ...
SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...
SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...
Canalevia ® (crofelemer delayed-release tablets), under the name Canalevia ®-CA1, is conditionally approved by the FDA for treatment of CID in dogs Company strategy: In discussions with multiple ...
The vaccine initially created to combat bacteria-induced diarrhea has recently demonstrated additional benefits, promoting accelerated growth in infant nonhuman primates. “The 160 million people ...
PORTLAND, Oregon -- A vaccine originally developed to prevent bacteria-caused diarrhea has now also been found to help infant nonhuman primates grow faster, according to a new study published in ...
Canalevia ® (crofelemer delayed-release tablets), under the name Canalevia ®-CA1, is conditionally approved by the FDA for treatment of CID in dogs Company strategy: In discussions with multiple ...